[350 Pages Report] Next Generation Sequencing (NGS) Market categories the global market by Platforms (MiSeq, Illumina HiSeq, 454 Roche, Life Technologies Ion Proton/PGM, by Bioinformatics (RNA-Seq, ChIP-Seq), (SBS, SMRT & Pyrosequencing,), (Diagnostics, Personalized Medicine) & by Geography.
The report "Molecular Breeding Market by Process (Qtl Mapping, Marker-Assisted Selection, Marker-Assisted Backcrossing, and Genomic Selection), Marker (Snp, Ssr), Application (Crop Breeding and Livestock Breeding), and Region-Global Forecast to 2023" The molecular breeding market is projected to reach USD 3.95 billion by 2023, from USD 1.79 billion in 2018, at a CAGR of 17.11% during the forecast period. Read more: https://www.marketsandmarkets.com/Market-Reports/molecular-breeding-market-168846611.html
The molecular breeding market is estimated at USD 1.79 billion in 2018 and is projected to reach USD 3.95 billion by 2023, at a CAGR of 17.11% during the forecast period. The agricultural benefits associated with these adjuvant solutions are the major factors contributing to the growth of this market, globally. The growth of economies in developing countries, coupled with the increasing R&D expenses in the agriculture industry drives the growth potential of these markets.
Next Generation Sequencing (NGS) Market categories the global market by Platforms (MiSeq, Illumina HiSeq, 454 Roche, Life Technologies Ion Proton/PGM, by Bioinformatics (RNA-Seq, ChIP-Seq), & by Geography
[350 Pages Report] Next Generation Sequencing (NGS) Market categories the global market by Platforms (MiSeq, Illumina HiSeq, 454 Roche, Life Technologies Ion Proton/PGM, by Bioinformatics (RNA-Seq, ChIP-Seq), & by Geography
his report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Illumina QIAGEN NeoGenomics Laboratories HTG Molecular Diagnostic Genomic Health
According to the Market Statsville Group (MSG), the global next generation sequencing market size is expected to grow from USD 9,345.0 million in 2022 to USD 58,254.4 million by 2033, at a CAGR of 18.1% from 2023 to 2033.
Next Generation Sequencing Market is expected to surpass US$ 30 Billion by the end of year 2025 with double digit CAGR during 2019-2025. Renub Research report titled “Next Generation Sequencing Market, Global NGS Forecast by End User, Type of Test, Disease, Informatics, Reimbursement, Company Analysis, Platform & Consumable" provides Next Generation Sequencing Market. Access full Research: https://www.renub.com/next-generation-sequencing-market-p.php
Get more details @ http://bit.ly/2nUpHlT Some of the key companies providing products and services in the digital genome market are Thermo Fisher, Perkin Elmer, Qiagen, Illumina, Becton Dickinson. Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, F. Hoffmann-La Roche, Agios, AVEO Oncology and Biomarin, BioReference.
Get more details @ http://bit.ly/2nUpHlT Some of the key companies providing products and services in the digital genome market are Thermo Fisher, Perkin Elmer, Qiagen, Illumina, Becton Dickinson. Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, F. Hoffmann-La Roche, Agios, AVEO Oncology and Biomarin, BioReference.
Next Generation Sequencing (NGS) Market is also termed as high-throughput sequencing. It is a DNA sequencing technology in which millions and billions DNA strands are sequenced. It has revolutionized genomic research, as it minimizes the requirement for fragment-cloning methods used in Sanger sequencing of genomes.
Next Generation Sequencing (NGS) Market is also termed as high-throughput sequencing. It is a DNA sequencing technology in which millions and billions DNA strands are sequenced. It has revolutionized genomic research, as it minimizes the requirement for fragment-cloning methods used in Sanger sequencing of genomes.
Global Mobile Apps for DNA Sequencing Market is expected to grow at a CAGR of 53.9% from 2017 to 2025. The report highlights the key trends, market outlook
The report provides an analysis of the key trends in each sub-segment of the global molecular cytogenetics market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, product type, technology, application and end user. For more information, request for a free sample report here: https://www.imarcgroup.com/molecular-cytogenetics-market/requestsample
Next Generation Sequencing (NGS) Market is also termed as high-throughput sequencing. It is a DNA sequencing technology in which millions and billions DNA strands are sequenced. It has revolutionized genomic research, as it minimizes the requirement for fragment-cloning methods used in Sanger sequencing of genomes.
The report provides an analysis of the key trends in each sub-segment of the global nucleic acid testing market report, along with forecasts for growth at the global, regional and country-level from 2020-2025. Our report has categorized the market based on region, product type, technology and end user. For more information, request for a free sample report here: https://www.imarcgroup.com/nucleic-acid-testing-market/requestsample
Global Biochip Products and Services Market (Product type, Application and Geography). The global biochip products and services market is expected to grow with high CAGR during forecast period, due to its increasing applications in drug discovery, genomics and proteomics. Furthermore, development of targeted and personalized medicines for treatment of cancer would also support the growth of biochip products.
iGATE Research has released a research report on “Global Next Generation Sequencing (NGS) Market (By Products - Consumables, Platforms, Services, Sequencing Services, Bioinformatics, Technology, Applications, End Users, Regions), Key Company Profiles - Forecast to 2025” Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=165 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
This report broadly segments the global next generation sequencing market into products & services, technology, application, and end user. The NGS market, by products & services is segmented into pre-sequencing products & services, NGS platforms, consumables, sequencing services, data analysis/bioinformatics.
Agrigenomics market is expected to reach USD 22.9 billion by 2027 growing at a growth rate of 7.80% in the forecast period of 2020 to 2027. Agrigenomics is the advancement of various post-sequencing analysis techniques and genomic technologies.
The report "Genomics Market by Product (Instruments, Consumables), by Technology (Sequencing, PCR, Microarray), by Application (Diagnostics, Personalized Medicine), by Process (Library Preparation, Sequencing & Imaging), by End User - Trends & Global Forecasts to 2020" , analyzes and studies the major market drivers, restraints/challenges, and opportunities.
The report “Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), by Research Area (Developmental Biology, Oncology) - Global Forecast to 2020", The epigenetics market is expected to reach USD 890.0 Million by 2020 from USD 469.6 Million in 2015, at a CAGR of 13.64% between 2015 and 2020.
The report segments the Global Genomics market by products (instrument, consumables, and services), by technology (Nucleic acid extraction & purification, PCR, DNA sequencing, and DNA microarray), by application (diagnostics, personalized medicine, academic research, agriculture & animal health, and academic research), and by geography (North America, Europe, APAC, and RoW).
The report "Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), by Research Area (Developmental Biology, Oncology) - Global Forecast to 2020", The epigenetics market is expected to reach USD 890.0 Million by 2020 from USD 469.6 Million in 2015, at a CAGR of 13.64% between 2015 and 2020.
The global next generation sequencing market is geographically segmented into North America, Europe, Asia, and Rest of the World, with North America contributing the highest share, followed by Europe.
However, accuracy & standardization concerns in diagnostic testing, lack of skilled professionals, and ethical & legal issues related to NGS are some of the key factors restraining the growth of this market. In addition to this, challenges associated with interpretation of complex data from NGS platforms and storage of sequencing data also limits the growth of the NGS market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPHE100000820 According to a new market research study titled 'Next Generation Sequencing Market to 2025 - Global Analysis and Forecasts by Product, Services, Applications, and End-Users, the global next generation sequencing market was valued at US$ 5,731.3 Mn in 2017 and is estimated to reach US$ 26,501.2 Mn by 2025. The report highlights the trends prevalent in the global next generation sequencing market and the factors driving the market along with those that act as deterrents to its growth.
Get more details @ http://bit.ly/2Fxow5K Notable HLA Typing for Transplant industry participants include Pacific Biosciences of California, Thermo Fischer Scientific, Immucor, Illumina, GenDx and CareDx.
The report "Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), by Research Area (Developmental Biology, Oncology) - Global Forecast to 2020", The epigenetics market is expected to reach USD 890.0 Million by 2020 from USD 469.6 Million in 2015, at a CAGR of 13.64% between 2015 and 2020.
Get more information about the market: http://www.imarcgroup.com/pasta-market IMARC Group’s latest report titled, “Pasta Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the market reached a value of more than US$ 11 Billion in 2016, growing at a CAGR of nearly 4% during 2009-2016. Request a sample report: http://www.imarcgroup.com/request?type=report&id=806&flag=B Browse more reports on Food & Beverages Industry: http://www.imarcgroup.com/categories/food-beverages-market-reports Contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Follow us on twitter: @imarcglobal
The global genetic testing market is estimated to exceed $9.8 billion by the year 2024, owing to increasing advancement in technology and increasing awareness. Also, the ability of genetic tests to determine breast cancer and genetic disorders at an early stage will help the market growth of DNA testing market. Get full report details at- https://goo.gl/c3w8XT
Global Market Estimates is a market research and business consulting company who has proven track record in serving Fortune 500 companies. Request for a sample copy of the ‘Metagenomics Market’ report @: https://www.globalmarketestimates.com/metagenomics-market/
The market is heavily consolidated owing to a large number of global, regional, and local key contenders having already established a significant footing.
“The future of genomics lies in the personalized medicine industry. Government initiatives and considerable investments are expected to drive genetic research on personalized medicines that utilize base pairs of the human genome sequence”.
Big Market Research has announced a new Healthcare market report “Next Generation Sequencing Global Market Outlook - Trends, Forecast, and Opportunity Assessment (2014-2022)” Get Complete Report @ http://www.bigmarketresearch.com/next-generation-sequencing-global-outlook-trends-forecast-and-opportunity-assessment-2014-2022-market The Global Next Generation Sequencing Market accounted for $2.8 billion in 2014 and is expected to grow at a CAGR of 21.7 % to reach $13.5 billion by 2022. Next-generation sequencing enables rapid sequencing and produces millions of DNA and RNA sequences. It is used in personalized medicines, clinical applications, animal research and other applications Enquire about this report @ http://www.bigmarketresearch.com/report-enquiry/359601
MedGenome Share Price will grow based on the company’s performance and on the current market conditions. MedGemome is a global leader in Genetic Testing services, Genomics Research, and drug discovery solutions. It operates a multi-pronged business model that capitalizes on the growing demand for personalized medicine and genetic insights. MedGenome has been committed to delivering world-class genomic solutions with greater precision and accuracy to empower every human being for better management of their health since 2013. MedGenome utilizes advanced technologies like Next-Generation Sequencing (NGS) for in-depth genetic analysis, aiding in complex diagnosis and personalized treatment plans. You can check the Planify website for the latest share price and news.
To Get sample Brochure now@ http://tinyurl.com/ja3aftd A detailed qualitative analysis of the factors responsible for driving and restraining growth of the DNA Sequencer Industry Market and future opportunities are provided in the report. The report makes some important proposals for a new project of DNA Sequencer Industry before evaluating its feasibility.
The global next-generation sequencing market is estimated to register a CAGR of 20.5% from 2017 to 2022 to reach USD 12.45 billion by 2022. Download Sample at http://bit.ly/2zigGOc . Factors such as technological advancements in NGS platforms, increasing applications of NGS, growing partnerships and collaborations, and increasing adoption of NGS among research laboratories and academic institutes are driving the growth of this market.
Global Biochips market Click to Get Sample @ http://goo.gl/NWSjx4 . It is categorized into four major segments, namely, hospitals & diagnostic centers, biotechnology & pharmaceutical companies, academic & research institutes, and other end users (blood banks, CROs, forensic labs, point-of-care settings, home health agencies, nursing homes, and local public health laboratories). Abbott Laboratories (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer Inc. (U.S.), Fluidigm Corporation (U.S.), Illumina, Inc. (U.S.), GE Healthcare (U.S.), Bio-Rad Laboratories Inc. (U.S.), Cepheid Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and F. Hoffmann-La Roche AG (Switzerland) are the major players in the biochips market.
Next-Generation Sequencing Market 2019 Fortune Business Insights report presents you analysis of market size, share, and growth, trends, and cost structure, statistical and comprehensive data of the global market.
cancer diagnostics market 2019 , cancer diagnostics market 2022,cancer diagnostics market, cancer diagnostics market report, cancer diagnostics market research, cancer diagnostics market outlook, cancer diagnostics market overview, cancer diagnostics market size, cancer diagnostics market trends, cancer diagnostics industry, healthcare, marketresearchfuture.com, global cancer diagnostics market, global cancer diagnostics market report, cancer diagnostics market india, cancer diagnostics market analysis
Research Report on Global Genomic Market is a professional and comprehensive report on the Genomic industry. The report monitors the key trends and market drivers in the current scenario and offers on-the-ground insights. https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941
According to #TechSci Research report, Global Precision Medicine Market, was valued USD66.85 billion in 2020 and is expected to reach USD125.67 billion, growing at CAGR of 10.65% during the forecast period. Gain More Insight: https://bit.ly/3Df5kr2 Get Sample Report: https://bit.ly/3kneqJG Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
The report gives detail analysis of the industry structure along with forecast, market size & share, different segments and developing trends of the industry.
Though most of healthcare solution providers are still evolving, there are larger drifts growing in healthcare, emergency services, pathology, and various among other things. Here in this special issue of ‘Emerging Healthcare Solution Providers to Watch in 2019’, we have enlightened the foremost Healthcare Solution Providers that are transforming the healthcare industry with their astounding services and approaches.
24 Market Reports has recently announced the addition of a new report on Agrigenomics Market. The study is aimed at presenting in-depth insights into the factors encouraging and inhibiting the market’s growth. The report is titled “USA Agrigenomics Market Report 2018” and is available for sale on the company website.